Netherlands Faces Medical Cannabis Supply Gap During System Transition

The Netherlands is experiencing a critical supply disruption in its medical cannabis program as Bedrocan, the primary cultivator, has suspended payments amid an incomplete transition to a new regulatory model. While the Dutch government maintains current cannabis reserves for patients, official acknowledgment indicates existing stockpiles will not sustain operations until the new system becomes fully operational. To bridge this gap and ensure continuity of care for patients dependent on medical cannabis, authorities are arranging emergency imports to prevent treatment interruptions. This transition highlights the operational challenges governments face when restructuring medical cannabis infrastructure and the importance of coordinated supply chain planning.